Granatus Ventures has invested in Modicus Prime, an AI-powered computer vision company specializing in quality control systems for the pharmaceutical industry, aiming to enhance its growth and global market presence.
Target Company Overview
Granatus Ventures, a prominent venture capital firm based in Armenia, has recently invested in Modicus Prime, an innovative AI-powered computer vision company. Modicus Prime specializes in developing advanced quality control systems tailored specifically for the pharmaceutical industry.
The company has created proprietary software solutions that offer real-time visual analysis of biological imagery. These solutions are designed to identify contamination and serve as a continuous, custom quality control tool for pharmaceutical research and development (R&D) as well as manufacturing processes, ensuring high accuracy and cost efficiency.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Armenia
The pharmaceutical industry in Armenia is experiencing significant growth, driven by the increasing demand for innovative healthcare solutions and advancements in technology. The
Similar Deals
Elaia, Pfizer Ventures, Bpifrance → Enodia Therapeutics
2026
Cardumen Capital → Biographica
2026
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
Granatus Ventures
invested in
Modicus Prime
in 2023
in a Seed Stage deal